Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 6-7, Juin–Juillet 2010
Page(s) 647 - 651
Section M/S revues
DOI https://doi.org/10.1051/medsci/2010266-7647
Publié en ligne 15 juin 2010
  1. Beaulieu JM, Sotnikova TD, Marion S. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005 ; 122 : 261-73.
  2. Beaulieu JM, Tirotta E, Sotnikova TD, et al. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 2007 ; 27 : 881-5.
  3. Galandrin S, Oligny-Longpré G, Bouvier M. The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci 2007 ; 28 : 423-30.
  4. Luttrell LM, Ferguson SS, Daaka Y, et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 1999 ; 283 : 655-61.
  5. Beaulieu JM, Gainetdinov RR, Caron MG. Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 2009 ; 49 : 327-47.
  6. Svenningsson P, Nishi A, Fisone G, et al. DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 2004 ; 44 : 269-96.
  7. Woodgett JR. Judging a protein by more than its name: GSK-3. Sci STKE 2001 ; 2001 : RE12.
  8. Beaulieu JM, Sotnikova TD, Yao WD, et al. Lithium antagonizes dopaminedependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 2004 ; 101 : 5099-104.
  9. Gainetdinov RR, Wetsel WC, Jones SR, et al. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999 ; 283 : 397-401.
  10. Prickaerts J, Moechars D, Cryns K, et al. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 2006 ; 26 : 9022-9.
  11. Gould TD, Einat H, O’Donnell KC, et al. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 2007 ; 32 : 2173-83.
  12. Beaulieu JM, Gainetdinov RR, Caron MG. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 2007 ; 28 : 166-72.
  13. Ferguson SS, Downey WE 3rd, Colapietro AM, et al. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 1996 ; 271 : 363-6.
  14. Lohse MJ, Benovic JL, Codina J, et al. beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science 1990 ; 248 : 1547-50.
  15. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science 2005 ; 308 : 512-7.
  16. Li X, Rosborough KM, Friedman AB, et al. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Int J Neuropsychopharmacol 2007 ; 10 : 7-19.
  17. Li X, Zhu W, Roh MS, et al. In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain. Neuropsychopharmacology 2004 ; 29 : 1426-31.
  18. Polter A, Yang S, Zmijewska AA, et al. Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation. Biol Psychiatry 2009 ; 65 : 150-9.
  19. Beaulieu JM, Zhang X, Rodriguiz RM, et al. Role of GSK3beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 2008 ; 105 : 1333-8.
  20. Emamian ES, Hall D, Birnbaum MJ, et al. Convergent evidence for impaired AKTL-GSK3beta signaling in schizophrenia. Nat Genet 2004 ; 36 : 131-7.
  21. Alimohamad H, Rajakumar N, Seah YH, Rushlow W. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol Psychiatry 2005 ; 57 : 533-42.
  22. Beaulieu JM. Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs. Int J Neuropsychopharmacol 2007 ; 10 : 3-6.
  23. Phiel CJ, Klein PS. Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 2001 ; 41 : 789-813.
  24. Beaulieu JM, Caron MG. Looking at lithium: molecular moods and complex behaviour. Mol Interv 2008 ; 8 : 230-41.
  25. Beaulieu JM, Marion S, Rodriguiz RM, et al. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 2008 ; 132 : 125-36.
  26. Kovacsics CE, Gottesman II, Gould TD. Lithium’s antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies. Annu Rev Pharmacol Toxicol 2009 ; 49 : 175-98.
  27. Mao Y, Ge X, Frank CL, et al. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 2009 ; 136 : 1017-31.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.